Copenhagen Master Observational Trial
NCT05145244 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2400
Last updated 2025-07-24
Summary
The primary objectives of this prospective non-interventional study (NIS) are to assess and describe outcomes in relation to biomarkers, including whole-genome sequencing (WGS) in patients with non- small cell lung cancer (NSCLC) or breast cancer receiving treatment offered in the clinic (standard of care or included in clinical trials).
Conditions
Interventions
- OTHER
-
NO intervention
No intervention
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2026-12-31
- Completion
- 2027-12-31
- FDA Drug
- Yes
Countries
- Denmark
Study Locations
More Related Trials
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT01585545 ·Status: ENROLLING_BY_INVITATION
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Patient's Whole Process Follow-up Management(HOPE-1)
NCT05339568 ·Status: RECRUITING
-
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 ·Status: UNKNOWN
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
NCT05468970 ·Status: RECRUITING
-
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 ·Status: COMPLETED
-
Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation
NCT02844400 ·Status: COMPLETED
-
Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients
NCT03529851 ·Status: COMPLETED ·Phase: NA
-
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
NCT03791034 ·Status: RECRUITING
-
Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
NCT05965557 ·Status: RECRUITING
-
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956 ·Status: COMPLETED
-
Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer
NCT05260606 ·Status: RECRUITING
-
Prospective Data Collection Initiative on Thoracic Malignancies
NCT06996249 ·Status: RECRUITING
-
Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer
NCT00867412 ·Status: COMPLETED
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer
NCT04918836 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
NCT01936571 ·Status: COMPLETED
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer
NCT00958555 ·Status: UNKNOWN
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN